MMELX | VMGMX | MMELX / VMGMX | |
Total Expense Ratio | 0.96 | 0.07 | 1,371% |
Annual Report Gross Expense Ratio | 0.97 | 0.07 | 1,386% |
Fund Existence | 25 years | 14 years | - |
Gain YTD | -12.853 | -6.902 | 186% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.81B | 27.2B | 14% |
Annual Yield % from dividends | 0.49 | 0.71 | 68% |
Returns for 1 year | -18.98 | 5.87 | -323% |
Returns for 3 years | -29.49 | 10.88 | -271% |
Returns for 5 years | -25.23 | 65.25 | -39% |
Returns for 10 years | -26.37 | 122.47 | -22% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FAVCX | 22.02 | N/A | N/A |
Fidelity Advisor Equity Value C | |||
FRBRX | 116.27 | N/A | N/A |
Franklin Biotechnology Discovery R6 | |||
PRMTX | 146.31 | N/A | N/A |
T. Rowe Price Comm & Tech Investor | |||
JIJIX | 12.94 | N/A | N/A |
JHancock International Dynamic Gr I | |||
WAFMX | 3.43 | -0.04 | -1.15% |
Wasatch Frontier Emerg Sm Countrs Inv |